Nutraceuticals:
CoQ10 for Chronic Pain: A Patient Guide
See:
Nutraceutical Patient Guides:
- Acetyl-L-Carnitine (ALC) for Chronic Pain: A Patient Guide
- Alpha-Lipoic Acid (ALA) for Chronic Pain: A Patient Guide
- Boswellia for Chronic Pain: A Patient Guide
- CoQ10 for Chronic Pain: A Patient Guide
- Curcumin for Chronic Pain: A Patient Guide
- Magnesium for Chronic Pain: A Patient Guide
- Melatonin for Chronic Pain: A Patient Guide
- N-Acetylcysteine (NAC) for Chronic Pain: A Patient Guide
- Nicotinamide Riboside (NAD+ Precursors) for Chronic Pain
- Omega-3 Fatty Acids for Chronic Pain: A Patient Guide
- Palmitoylethanolamide (PEA) for Chronic Pain- A Patient Guide
- Quercetin for Chronic Pain: A Patient Guide
- Resveratrol for Chronic Pain: A Patient Guide
- Sulforaphane (SFN) for Chronic Pain: A Patient Guide
- Taurine for Chronic Pain: A Patient Guide
- Vitamin D for Chronic Pain: A Patient Guide

Key to Links:
- Grey text – handout
- Red text – another page on this website
- Blue text – Journal publication
Definitions and Terms Related to Pain
CoQ10 for Chronic Pain: A Patient Guide
1. OVERVIEW
Coenzyme Q10 (CoQ10), also known as ubiquinone, is a naturally occurring vitamin-like compound found in every cell of the body. It plays an essential role in the mitochondria—the “power stations” of cells—where it is critical for producing ATP, the energy compound that powers all cellular functions.[1][2] CoQ10 also serves as a potent antioxidant, protecting cells from oxidative damage and has it significant anti-inflammatory properties as well.[3][4]
What makes CoQ10 valuable for chronic pain:
- It is an essential cofactor for mitochondrial energy (ATP) production—critical for tissues with high energy demands like muscles and nerves[1][2]
- Powerful antioxidant that neutralizes free radicals and reduces oxidative stress[3][4]
- Anti-inflammatory agent that inhibits NF-κB and NLRP3 inflammasome pathways that contribute to systemic and neuroinflammation[5][6]
- Restores CoQ10 deficiency often found in fibromyalgia and other chronic pain conditions[7][6]
- Supports mitochondrial production and function[6][8]
- Activates AMPK, a master regulator of cellular energy metabolism[6]
- Excellent safety profile with minimal side effects and low drug interaction potential[9][10]
How CoQ10 Compares to Conventional Medications:
A randomized, double-blind, placebo-controlled trial in fibromyalgia patients found that 40 days of CoQ10 supplementation (300 mg/day) produced significant reductions in pain (p0.001), fatigue, and morning tiredness compared to placebo, along with reductions in tender points and improvements in the Fibromyalgia Impact Questionnaire, Revised (FIQR).[6] Another RCT demonstrated that CoQ10 added to pregabalin (Lyrica) provided significantly greater pain relief than pregabalin alone in fibromyalgia patients, while also reducing mitochondrial oxidative stress and inflammation.[11]
In painful diabetic neuropathy, an RCT of 112 patients found that CoQ10 (300 mg/day) added to pregabalin resulted in significantly greater pain reduction than pregabalin plus placebo at weeks 4 and 8 (p=0.01 and p0.001, respectively), with a higher proportion of patients achieving ≥50% pain reduction.[1]
Unlike many conventional pain medications, CoQ10 does not cause sedation, cognitive impairment, or dependence. It works best as an “add-on” therapy to enhance the effects of other treatments while addressing underlying mitochondrial dysfunction and oxidative stress.[7][11]
—
2. DIETARY SOURCES
CoQ10 is found naturally in various foods:[4][12]
- Organ meats (heart, liver, kidney): Highest concentrations
- Beef and pork: Good sources
- Chicken: Moderate amounts
- Fatty fish (sardines, mackerel, trout): Good sources
- Soybeans and soybean oil: Plant sources
- Peanuts: Moderate amounts
- Spinach and broccoli: Lower amounts
- Whole grains: Small amounts
Important Bioavailability Note: The average dietary intake of CoQ10 is only 3–6 mg per day—far below therapeutic doses of 100–400 mg/day used in clinical trials.[4][12] Additionally, native CoQ10 is highly lipophilic (fat-soluble) with poor oral bioavailability, as absorption efficiency varies significantly depending on formulation.[1][2]
Key absorption considerations:
- CoQ10 is absorbed in the small intestine with the aid of bile and pancreatic secretions[1]
- After absorption, it is incorporated into chylomicrons and transported via lymphatics[1]
- Maximum plasma concentration occurs 6–8 hours after ingestion with a half-life >30 hours[1]
- Solubilized and water-dispersible formulations significantly improve absorption[1][5]
- Taking CoQ10 with food (especially fat-containing meals) enhances absorption
—
3. INDICATIONS FOR NUTRACEUTICAL SUPPLEMENTATION
Pain Conditions with Moderate to High Quality Evidence:
Fibromyalgia – Moderate-High Quality Evidence
- RCT (20 patients): CoQ10 300 mg/day for 40 days significantly reduced pain (p0.001), fatigue, morning tiredness, and tender points compared to placebo[6]
- RCT (11 patients): CoQ10 added to pregabalin provided greater pain relief than pregabalin alone, with reduced brain activity and mitochondrial dysfunction[11]
- Open-label study (22 patients): Water-soluble CoQ10 400 mg/day improved pain outcomes by 24–37%, fatigue by ~22%, and sleep disturbance by ~33%[13]
- Low CoQ10 levels have been documented in fibromyalgia patients, and supplementation restores these levels[7][6]
Painful Diabetic Neuropathy – Moderate Quality Evidence
- RCT (112 patients): CoQ10 300 mg/day + pregabalin resulted in significantly greater pain reduction than placebo + pregabalin at weeks 4 and 8[1]
- Higher proportion of responders (≥50% pain reduction) in CoQ10 group[1]
- Improved sleep interference scores[1]
Migraine Prevention – Moderate Quality Evidence
- Meta-analysis (6 RCTs, 371 patients): CoQ10 reduced migraine frequency (MD: -1.52 attacks/month, p0.001) and duration of headache attacks (MD: -0.19 hours, p0.00001)[14]
- Meta-analysis (4 RCTs, 221 patients): CoQ10 reduced migraine frequency by 1.87 attacks/month (p0.001)[14] Dose-response meta-analysis: CoQ10 decreased migraine frequency (MD = -1.73), severity (MD = -1.35), and duration (MD = -1.72)[15]
Chronic Fatigue Syndrome/ME/CFS – Moderate Quality Evidence
- RCT (207 patients): CoQ10 200 mg + NADH 20 mg daily significantly reduced cognitive fatigue and improved health-related quality of life[16]
- RCT (73 patients): CoQ10 + NADH improved fatigue scores and biochemical parameters (ATP, NAD+/NADH ratio)[17]
- Meta-analysis (13 RCTs, 1,126 participants): CoQ10 significantly reduced fatigue scores (Hedges’ g = -0.398, p=0.001)[18]
Statin-Associated Muscle Symptoms (SAMS) – Low-Moderate Quality Evidence
- Meta-analysis (12 RCTs, 575 patients): CoQ10 significantly ameliorated muscle pain (p0.001), weakness (p=0.006), cramps (p0.001), and fatigue (p0.001)[1]
- Statins inhibit CoQ10 synthesis via the mevalonate pathway, potentially contributing to muscle symptoms[1][14]
Summary:
The evidence base for CoQ10 in chronic pain is strongest for fibromyalgia, painful diabetic neuropathy, migraine prevention, and chronic fatigue syndrome, with its primary mechanisms being mitochondrial support and antioxidant effects rather than the neuroinflammatory/mast cell modulation seen with PEA.
4. CoQ10’S IMPACT ON PAIN CONDITIONS
CoQ10 addresses the underlying pathophysiology of chronic pain conditions through multiple mechanisms:
Mitochondrial Function Restoration:
- Essential electron carrier in the mitochondrial respiratory chain (Complexes I, II, and III)[1][2]
- Restores ATP production in energy-depleted tissues[2][19]
- Increases mitochondrial biogenesis through AMPK activation[6]
- Improves mitochondrial membrane stability[2]
Oxidative Stress Reduction:
- Potent lipophilic antioxidant in its reduced form (ubiquinol)[1][3]
- Scavenges free radicals and reactive oxygen species[3][4]
- Reduces lipid peroxidation (malondialdehyde levels)[4][19]
- Increases total antioxidant capacity and glutathione levels[11][19]
- Enhances superoxide dismutase (SOD) and catalase activity[19][20]
Anti-Inflammatory Effects:
- Inhibits NF-κB inflammatory signaling pathway[5][6][21]
- Reduces NLRP3 inflammasome activation[5][6]
- Decreases pro-inflammatory cytokines (TNF-α, IL-1β, IL-6)[4][20][22]
- Reduces COX-2 expression and prostaglandin E2 production[21]
Cellular Energy Support:
- Particularly important for tissues with high metabolic demands (muscle, nerve, brain)[1][2]
- Addresses the “energy deficit” hypothesis in conditions like fibromyalgia and ME/CFS[7][16]
—
5. CoQ10’S IMPACT ON PAIN PROCESSING
Pain processing refers to how pain signals are processed from the initial damaged tissue source of pain through the nerves and spinal cord to the brain and then down the spinal cord again. Nutraceuticals offer potential benefit for reducing the severity of the pain experience by acting at various levels of pain processing. These benefits are independent of the benefits the nutraceutical offers at the source of pain.
The Levels of Pain Processing can be organized as follows:
- Level 1: Peripheral Nociception (Pain Receptor Transduction)
- Level 2: Primary Afferent Transmission to Spinal Cord
- Level 3: Spinal Cord Dorsal Horn Processing (First Synapse)
- Level 4: Ascending Spinal Pathways and Supraspinal Processing
- Level 5: Thalamic and Cortical Brain Processing and Pain Perception
- Level 6: Descending Pain Modulation
Level 1: Peripheral Pain Receptor (Nociception Transduction)
CoQ10 may modulate peripheral nociception through:
- Reduction of local oxidative stress that sensitizes pain receptors[3][4]
- Anti-inflammatory effects reducing prostaglandins and cytokines at tissue level[4][5]
- Protection of peripheral nerve endings from oxidative damage[23]
Level 2: Primary Afferent Transmission to Spinal Cord
CoQ10 supports healthy nerve signal transmission:
- Maintains mitochondrial function in peripheral nerve fibers[2][23]
- Protects nerve fibers from oxidative and inflammatory damage[23]
- Supports energy production needed for proper nerve conduction[2]
Level 3: Spinal Cord Dorsal Horn Processing (First Synapse)
CoQ10 may affect spinal cord processing through:
- Reduction of spinal oxidative stress[3][4]
- Anti-inflammatory effects reducing spinal neuroinflammation[5][6]
- Support of mitochondrial function in spinal cord neurons[2]
Level 4: Ascending Spinal Pathways and Supraspinal Processing
CoQ10 affects higher pain processing centers:
- Neuroprotective effects in brain regions[23][24]
- Reduction of neuroinflammation through NF-κB inhibition[5][21]
- Modulation of microglial activation[20][24]
Level 5: Brain Cortical Processing and Pain Perception
CoQ10 modulates the conscious experience of pain through:
- Reduction of brain activity in pain-processing regions (demonstrated by PET scan in fibromyalgia patients)[11]
- Neuroprotective effects in cortical regions[23][24]
- Reduction of anxiety associated with chronic pain[11]
- Support of cognitive function and reduction of fatigue[16][18]
Level 6: Descending Pain Modulation
CoQ10 may support descending inhibitory pathways through:
- Enhancement of BDNF expression via PGC-1α/FNDC5/BDNF pathway[25]
- Support of mitochondrial function in brainstem nuclei[2]
- Reduction of neuroinflammation affecting descending modulation[5][24]
Clinical Evidence for Effects on Pain Processing:
A double-blind RCT in fibromyalgia patients demonstrated that CoQ10 supplementation significantly reduced brain activity on PET scan compared to placebo, correlating with improved pain outcomes. This suggests CoQ10 affects central pain processing mechanisms.[11]
—
6. BENEFITS FOR PAIN SENSITIZATION
Peripheral Sensitization: MODERATE Quality Evidence
CoQ10 may reduce peripheral sensitization through:
- Reduction of peripheral oxidative stress that sensitizes nociceptors[3][4]
- Anti-inflammatory effects reducing local inflammatory mediators[4][5]
- Protection of peripheral nerve fibers from damage[23]
- Restoration of mitochondrial function in peripheral tissues[2]
Central Sensitization: MODERATE Quality Evidence
CoQ10 addresses central sensitization through:
- Reduction of brain activity in pain-processing regions (PET scan evidence)[11]
- Inhibition of NF-κB and NLRP3 inflammasome pathways in CNS[5][6]
- Neuroprotective effects reducing neuronal damage[23][24]
- Modulation of microglial activation[20][24]
- Enhancement of BDNF expression supporting neuroplasticity[25]
- Reduction of oxidative stress in CNS tissues[3][4]
—
7. CoQ10’S IMPACT ON THE 4 DRIVING FORCES OF CHRONIC PAIN
1. Systemic Inflammation: MODERATE EFFECT
CoQ10 reduces systemic inflammation through:
- Meta-analysis evidence: CoQ10 significantly decreased TNF-α levels (MD = -0.45 pg/ml, p0.001)[4]
- Inhibition of NF-κB inflammatory signaling pathway[5][6][21]
- Reduction of NLRP3 inflammasome activation[5][6]
- Decreased pro-inflammatory cytokines (IL-1β, IL-6)[20][22]
- Reduction of COX-2 and prostaglandin E2[21]
2. Neuroinflammation: MODERATE EFFECT
CoQ10 reduces neuroinflammation through:
- Inhibition of NF-κB pathway in neural tissues[5][21]
- Modulation of microglial activation[20][24]
- Reduction of neuroinflammatory cytokines (TNF-α, IL-6) in brain tissue[20][24]
- Neuroprotective effects preventing neuronal damage[23][24]
- Activation of autophagy pathways (Beclin-1, ULK-1)[20]
3. Oxidative Stress: STRONG EFFECT (Primary Mechanism)
This is one of CoQ10’s primary mechanisms of action:
- Meta-analysis (34 RCTs, 2,012 participants): CoQ10 significantly increased total antioxidant capacity and reduced malondialdehyde[19]
- Potent lipophilic antioxidant in reduced form (ubiquinol)[1][3]
- Increases glutathione (GSH) levels[11][19]
- Enhances superoxide dismutase (SOD) and catalase activity[11][19][20]
- Reduces lipid peroxidation and protein oxidation[19][20]
- Protects mitochondrial DNA from oxidative damage[2][19]
4. Mitochondrial Dysfunction: STRONG EFFECT (Primary Mechanism)
This is CoQ10’s primary mechanism of action:
- Essential electron carrier in mitochondrial respiratory chain[1][2]
- Restores ATP production in energy-depleted cells[2][19]
- Increases mitochondrial biogenesis through AMPK activation[6]
- Stabilizes mitochondrial membranes[2]
- Inhibits mitochondrial permeability transition pore[2]
- Restores mtDNA copy number[8]
- Improves electron transport chain complex activities[20]
Summary:
The evidence base for CoQ10 in chronic pain is strongest for fibromyalgia, painful diabetic neuropathy, migraine prevention, and chronic fatigue syndrome, with its primary mechanisms being mitochondrial support and antioxidant effects rather than the neuroinflammatory/mast cell modulation seen with PEA.
—
8. DOSING, TIMING, DURATION AND ADMINISTRATION
Recommended Dosing:
Fibromyalgia
- Dose: 200–400 mg
- Frequency: Divided 2–3 times daily
- Duration: Minimum 40–60 days
Painful Diabetic Neuropathy
- Dose: 300 mg
- Frequency:100 mg three times daily
- Duration: Minimum 8 weeks
Migraine prevention
- Dose: 100–400 mg
- Frequency: Once daily or divided
- Duration: Minimum 3 months
Chronic fatigue syndrome
- Dose: 200–400 mg
- Frequency: Once daily or divided
- Duration: Minimum 8–12 weeks
Statin-associated muscle symptoms
- Dose: 200–400 mg
- Frequency: Once daily or divided
- Duration: Ongoing
General chronic pain
- Dose: 100–300 mg
- Frequency: Once daily or divided
- Duration: Minimum 8 weeks
Key Dosing Points:
- Most clinical trials for pain conditions used 200–400 mg/day[6][11][1][13]
- For cardiovascular conditions, 100–400 mg/day is typical; for neurodegenerative diseases, 600–3,000 mg/day has been used[1]
- A U-shaped dose-response relationship has been observed for some outcomes, with 100–200 mg/day showing optimal effects for blood pressure reduction[26]
- For oxidative stress reduction, 100–150 mg/day appears optimal[19]
- Gastrointestinal side effects are minimized by dividing doses to no more than 100 mg per dose[2]
Timing:
- Take with food, preferably a fat-containing meal, to enhance absorption[1][2]
- Divide total daily dose into 2–3 doses throughout the day
- Maximum plasma concentration occurs 6–8 hours after ingestion[1]
Duration of Onset:
- Early effects: Some improvement may be noticed within 2–4 weeks[1]
- Meaningful improvement: Typically 4–8 weeks for significant effects[6][11][1]
- Optimal effects: 8–12 weeks for full therapeutic benefit[16][18]
- Meta-regression shows greater fatigue reduction with longer treatment duration[18]
—
9. FORMULATION CONSIDERATIONS
Forms of CoQ10:
Ubiquinone (oxidized form):
- Most common and well-studied form
- Converted to ubiquinol after absorption
- Generally less expensive
- Stable and well-characterized
Ubiquinol (reduced form):
- Active antioxidant form
- Some studies suggest superior bioavailability[1]
- May be preferred in older adults or those with absorption issues
- More expensive and less stable
Formulation Types:
- Powder-filled capsules: Lowest bioavailability
- Oil suspensions in soft gel capsules: Improved absorption
- Water-soluble/dispersible formulations: Significantly improved bioavailability[1][5]
- Solubilized formulations: Produce highest plasma responses[1]
Clinical Evidence for Formulation:
A water-soluble CoQ10 formulation improved intracellular distribution and promoted mitochondrial respiration more effectively than native CoQ10 in cell studies.[5] Clinical trials using water-soluble CoQ10 in fibromyalgia showed significant improvements in pain, fatigue, and sleep.[13]
Quality Considerations:
- Choose solubilized or water-dispersible formulations for optimal absorption
- Look for products from reputable manufacturers with quality certifications
- Consider ubiquinol for older adults or those with malabsorption issues
- Crystal dispersion in formulation is important—absence reduces bioavailability by 75%[2]
—
10. SYNERGIES WITH OTHER PAIN MEDICATIONS AND NUTRACEUTICALS
Nutraceuticals:
- NADH (Nicotinamide Adenine Dinucleotide): Multiple RCTs show CoQ10 + NADH combination significantly improves fatigue, cognitive function, and quality of life in ME/CFS patients. The combination addresses both electron transport chain function and NAD+/NADH ratio.[16][17]
- Selenium: Open-label study showed CoQ10 400 mg + selenium 200 μg daily improved fatigue severity and quality of life while reducing oxidative stress and inflammatory cytokines in ME/CFS.[22]
- Alpha-lipoic acid: Complementary antioxidant with mitochondrial support; both are effective for migraine prevention.[15]
- Magnesium: Both reduce migraine frequency; complementary mechanisms (CoQ10 for mitochondrial function, magnesium for neuronal stability).[15]
- Riboflavin (Vitamin B2): Both support mitochondrial function and are recommended for migraine prevention; may have additive effects.[27]
- PEA (Palmitoylethanolamide): Complementary mechanisms—CoQ10 addresses mitochondrial dysfunction and oxidative stress while PEA targets neuroinflammation and mast cell activation.
Conventional Medications:
- Pregabalin: RCTs demonstrate CoQ10 + pregabalin provides significantly greater pain relief than pregabalin alone in both fibromyalgia and painful diabetic neuropathy.[11][1]
- Statins: CoQ10 supplementation may help prevent or ameliorate statin-associated muscle symptoms, as statins inhibit CoQ10 synthesis via the mevalonate pathway. A trial of CoQ10 200–400 mg daily is reasonable in patients with SAMS.[1][14]
- Standard fibromyalgia medications: CoQ10 can be safely added to anticonvulsants and antidepressants.[7][11]
—
11. DRUG INTERACTIONS
No Significant Drug Interactions Identified:
CoQ10 has minimal drug interaction potential and is generally considered safe to combine with most medications.[9][10]
Potential Interactions to Monitor:
- Warfarin: Case reports have associated CoQ10 with decreased INR in patients on warfarin; however, a randomized, double-blind, placebo-controlled crossover trial found no effect on INR. Caution is advised, and INR should be monitored when starting CoQ10 in patients on warfarin.[1][14]
- Hypoglycemic agents: CoQ10 may improve glycemic control in diabetic patients, potentially necessitating dosage reduction of diabetes medications.[1]
- Antihypertensive medications: CoQ10 may lower blood pressure (meta-analysis showed ~5 mmHg reduction in systolic BP), and adjustment in antihypertensive medications may be needed.[1][26]
- Beta-blockers: May lower endogenous CoQ10 levels.[1]
Safe Combinations:
- Can be safely combined with pregabalin, gabapentin, duloxetine, and other pain medications[11][1]
- No interactions with cytochrome P450 enzymes have been reported
- Safe to combine with other antioxidant supplements
Always inform your healthcare provider about all supplements you take.
—
12. SAFETY AND CONTRAINDICATIONS
Excellent Safety Profile:
CoQ10 has low toxicity and does not induce serious adverse effects in humans.[9][10]
- The acceptable daily intake (ADI) is 12 mg/kg/day, calculated from the NOAEL of 1,200 mg/kg/day in chronic toxicity studies—equivalent to 720 mg/day for a 60 kg person[9]
- The observed safety level (OSL) based on clinical trial data is 1,200 mg/day[9]
- Meta-analysis of fatigue studies reported only one adverse (gastrointestinal) event in 602 participants receiving CoQ10[18]
- No significant toxicity observed in human studies at doses up to 3,000 mg/day for neurodegenerative diseases[1]
Possible Side Effects (rare and usually mild):
- Gastrointestinal symptoms: nausea, diarrhea, dyspepsia, decreased appetite[1][2]
- Activation insomnia (rare)[1]
- Dizziness (rare)[1]
- Gastrointestinal side effects are minimized by dividing doses to ≤100 mg per dose[2]
Contraindications:
- Known allergy to CoQ10 or related compounds
- Pregnancy and breastfeeding (insufficient safety data, though no adverse effects have been reported)
Who Should Use Caution:
- Patients on warfarin (monitor INR)
- Patients on diabetes medications (may need dose adjustment)
- Patients on antihypertensive medications (may need dose adjustment)
Important Safety Note:
Exogenous CoQ10 does not influence the biosynthesis of endogenous CoQ10, nor does it accumulate in plasma or tissues after cessation of supplementation.[9]
—
13. SPECIAL CONSIDERATIONS / TIPS
- Formulation matters: Choose solubilized, water-dispersible, or soft gel oil-based formulations for optimal absorption
- Take with food: Fat-containing meals enhance absorption significantly
- Be patient: Allow 4–8 weeks for meaningful improvement; benefits continue to increase with longer treatment
- Divide doses: Split total daily dose into 2–3 doses to minimize GI side effects and maintain steady levels
- Consider ubiquinol: For older adults or those with absorption issues, the reduced form may be better absorbed
- Statin users: If taking statins, CoQ10 supplementation may help prevent muscle symptoms
- Combination therapy: CoQ10 works best as an add-on to existing treatments, not as a replacement
- Quality products: Choose reputable brands with third-party testing
- No tolerance or dependence: Unlike opioids, CoQ10 does not cause tolerance, dependence, or withdrawal
- No cognitive effects: CoQ10 does not cause sedation or cognitive impairment
- Monitor if on warfarin: Check INR when starting CoQ10
—
14. COSTS
- Standard ubiquinone (100–200 mg capsules): $15–30 per month (at 200–400 mg/day)
- Ubiquinol (reduced form): $25–50 per month
- Water-soluble/enhanced absorption formulations: $30–60 per month
- Combination products (CoQ10 + NADH, CoQ10 + selenium): $35–70 per month
CoQ10 is available as a dietary supplement without prescription. It is generally affordable compared to many prescription pain medications and has minimal drug interactions that would require additional monitoring costs. Higher-quality, better-absorbed formulations may be worth the additional cost for improved efficacy.
—
Remember: CoQ10 works best as part of a comprehensive pain management plan that includes proper medical care, physical activity, stress management, and healthy nutrition. CoQ10 is particularly valuable for conditions involving mitochondrial dysfunction, oxidative stress, and energy deficits—such as fibromyalgia, chronic fatigue syndrome, and migraine. Its excellent safety profile makes it suitable for long-term use. Always discuss any new supplement with your healthcare provider before starting.
The evidence base for CoQ10 in chronic pain is strongest for fibromyalgia, painful diabetic neuropathy, migraine prevention, and chronic fatigue syndrome, with its primary mechanisms being mitochondrial support and antioxidant effects rather than the neuroinflammatory/mast cell modulation seen with PEA.
References
- Targeted Treatment of Age-Related Fibromyalgia With Supplemental Coenzyme Q10. Hargreaves IP, Mantle D. Advances in Experimental Medicine and Biology. 2021;1286:77-85. doi:10.1007/978-3-030-55035-6_5.
- Coenzyme Q10 Supplementation Alleviates Pain in Pregabalin-Treated Fibromyalgia Patients Reducing Brain Activity and Mitochondrial Dysfunction. Sawaddiruk P, Apaijai N, Paiboonworachat S, et al. Free Radical Research. 2019;53(8):901-909. doi:10.1080/10715762.2019.1645955.
- Coenzyme Q10 as a Potential Add-on Treatment for Patients Suffering From Painful Diabetic Neuropathy: Results of a Placebo-Controlled Randomized Trial. Amini P, Sajedi F, Mirjalili M, Mohammadi Y, Mehrpooya M. European Journal of Clinical Pharmacology. 2022;78(12):1899-1910. doi:10.1007/s00228-022-03407-x.
- Can Coenzyme Q10 Improve Clinical and Molecular Parameters in Fibromyalgia?. Cordero MD, Alcocer-Gómez E, de Miguel M, et al. Antioxidants & Redox Signaling. 2013;19(12):1356-61. doi:10.1089/ars.2013.5260.
- Oral Coenzyme Q10 Supplementation Improves Clinical Symptoms and Recovers Pathologic Alterations in Blood Mononuclear Cells in a Fibromyalgia Patient. Cordero MD, Cotán D, del-Pozo-Martín Y, et al. Nutrition (Burbank, Los Angeles County, Calif.). 2012 Nov-Dec;28(11-12):1200-3. doi:10.1016/j.nut.2012.03.018.
- Coenzyme Q10: Clinical Applications Beyond Cardiovascular Diseases. Testai L, Martelli A, Flori L, Cicero AFG, Colletti A. Nutrients. 2021;13(5):1697. doi:10.3390/nu13051697.
- Coenzyme Q10 and Intracellular Signalling Pathways: Clinical Relevance. Mantle D. International Journal of Molecular Sciences. 2025;26(22):11024. doi:10.3390/ijms262211024.
- Coenzyme Q Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases. Gutierrez-Mariscal FM, Arenas-de Larriva AP, Limia-Perez L, et al. International Journal of Molecular Sciences. 2020;21(21):E7870. doi:10.3390/ijms21217870.
- Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis. Zhai J, Bo Y, Lu Y, Liu C, Zhang L. PloS One. 2017;12(1):e0170172. doi:10.1371/journal.pone.0170172.
- Coenzyme Q Inhibits NLRP3 Inflammasome Activation Through Mitophagy Induction in LPS/ATP-Stimulated Macrophages. Hseu YC, Tseng YF, Pandey S, et al. Oxidative Medicine and Cellular Longevity. 2022;2022:4266214. doi:10.1155/2022/4266214.
- Coenzyme Q10 Ameliorates Lipopolysaccharide-Induced Acute Lung Injury by Attenuating Oxidative Stress and NLRP3 Inflammation Through Regulating Mitochondrial Dynamics. Chen Y, Yang H, Hu X, et al. International Immunopharmacology. 2024;141:112941. doi:10.1016/j.intimp.2024.112941.
- Role for a Water-Soluble Form of CoQ10 in Female Subjects Affected by Fibromyalgia. A Preliminary Study. Di Pierro F, Rossi A, Consensi A, Giacomelli C, Bazzichi L. Clinical and Experimental Rheumatology. 2017 May-Jun;35 Suppl 105(3):20-27.
- Coenzyme Q10 Ameliorates Fibromyalgia-Like Symptoms and Cognitive Deficits by Enhancing Hippocampal PGC-1α/FNDC5/BDNF Pathway in Reserpine-Treated Rats. Belviranlı M, Okudan N, Sezer T. Molecular Neurobiology. 2025;63(1):248. doi:10.1007/s12035-025-05585-y.
- Coenzyme Q for Patients With Cardiovascular Disease: JACC Focus Seminar. Raizner AE, Quiñones MA. Journal of the American College of Cardiology. 2021;77(5):609-619. doi:10.1016/j.jacc.2020.12.009.
- Coenzyme Q10 Contents in Foods and Fortification Strategies. Pravst I, Zmitek K, Zmitek J. Critical Reviews in Food Science and Nutrition. 2010;50(4):269-80. doi:10.1080/10408390902773037.
- Coenzyme Q10 in the Diet–Daily Intake and Relative Bioavailability. Weber C, Bysted A, Hølmer G. Molecular Aspects of Medicine. 1997;18 Suppl:S251-4. doi:10.1016/s0098-2997(97)00003-4.
- Micronutrient Deficiencies an Unmet Need in Heart Failure. Soukoulis V, Dihu JB, Sole M, et al. Journal of the American College of Cardiology. 2009;54(18):1660-73. doi:10.1016/j.jacc.2009.08.012.
- Bioavailability of Coenzyme Q: An Overview of the Absorption Process and Subsequent Metabolism. Mantle D, Dybring A. Antioxidants (Basel, Switzerland). 2020;9(5):E386. doi:10.3390/antiox9050386.
- Integrating Complementary Medicine Into Cardiovascular Medicine. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). Vogel JH, Bolling SF, Costello RB, et al. Journal of the American College of Cardiology. 2005;46(1):184-221. doi:10.1016/j.jacc.2005.05.031.
- Safety Assessment of Coenzyme Q10 (CoQ10). Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K. BioFactors (Oxford, England). 2008;32(1-4):199-208. doi:10.1002/biof.5520320124.
- Coenzyme Q10 and Heart Failure: A State-of-the-Art Review. Sharma A, Fonarow GC, Butler J, Ezekowitz JA, Felker GM. Circulation. Heart Failure. 2016;9(4):e002639. doi:10.1161/CIRCHEARTFAILURE.115.002639.
- Coenzyme Q10. Bonakdar RA, Guarneri E. American Family Physician. 2005;72(6):1065-70.
- Coenzyme Q10 Supplementation for Prophylaxis in Adult Patients With Migraine-a Meta-Analysis. Sazali S, Badrin S, Norhayati MN, Idris NS. BMJ Open. 2021;11(1):e039358. doi:10.1136/bmjopen-2020-039358.
- Management of Headache (2023). Jane Abanes PhD DNP MSN/Ed PMHCNS PMHNP-BC RN, Natasha M. Antonovich PharmD BCPS, Andrew C. Buelt DO, et al. Department of Veterans Affairs.
- Effect of Coenzyme Q10 Supplementation on Clinical Features of Migraine: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Parohan M, Sarraf P, Javanbakht MH, Ranji-Burachaloo S, Djalali M. Nutritional Neuroscience. 2020;23(11):868-875. doi:10.1080/1028415X.2019.1572940.
- Effects of Selected Dietary Supplements on Migraine Prophylaxis: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Talandashti MK, Shahinfar H, Delgarm P, Jazayeri S. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2025;46(2):651-670. doi:10.1007/s10072-024-07794-0.
- Efficacy of CoQ10 as Supplementation for Migraine: A Meta-Analysis. Zeng Z, Li Y, Lu S, Huang W, Di W. Acta Neurologica Scandinavica. 2019;139(3):284-293. doi:10.1111/ane.13051.
Emphasis on Education
Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.
For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.
Should you wish more information regarding any of the subjects listed – or not listed – here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.
For more information, please contact Accurate Clinic.
Supplements recommended by Dr. Ehlenberger may be purchased commercially online
Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.
.